CONMED Corporation Announces First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- S&P Global explores potential separation of Capital IQ business
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Ladenburg Thalmann Downgrades CONMED (CNMD) to Neutral
April 24, 2015 8:19 AM EDTLadenburg Thalmann downgraded CONMED (NASDAQ: CNMD) from Buy to Neutral with a price target of $55 (unchanged).
For an analyst ratings summary and ratings history on CONMED click here. For more ratings news on CONMED click here.
Shares of CONMED closed at $54.23 yesterday.
... MoreConmed (CNMD) Misses Q1 EPS by 2c, Offers FY15 Guidance
April 22, 2015 4:52 PM EDTConmed (NASDAQ: CNMD) reported Q1 EPS of $0.42, $0.02 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $177.9 million versus the consensus estimate of $176.16 million.
Conmed sees FY2015 EPS of $1.82-$1.92, versus the consensus of $1.86. Conmed sees FY2015 revenue of $723-738... More



